Joseph Benesch insider trades: Journey Medical (DERM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joseph reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 2, 2025 | DERM | ↓ Sell | 2,409 | $6.84 | $16K | Direct | May 5, 2025 (3d) |
| Feb 21, 2025 | DERM | ↓ Sell | 1,365 | $5.19 | $7K | Direct | Feb 24, 2025 (3d) |
| Aug 1, 2024 | DERM | ↓ Sell | 9,324 | $5.47 | $51K | Direct | Aug 1, 2024 (0d) |
| Jul 23, 2024 | DERM | ↓ Sell | 4,055 | $5.40 | $22K | Direct | Jul 23, 2024 (0d) |
| Feb 22, 2024 | DERM | ↓ Sell | 2,450 | $3.75 | $9K | Direct | Feb 23, 2024 (1d) |
| Jul 24, 2023 | DERM | ↓ Sell | 4,072 | $1.76 | $7K | Direct | Jul 25, 2023 (1d) |
| Feb 22, 2023 | DERM | ↓ Sell | 2,768 | $1.97 | $5K | Direct | Feb 23, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Joseph Benesch's insider trades
Joseph Benesch is CFO at Journey Medical (DERM). Since Feb 22, 2023, Joseph has reported no open-market purchases and 7 sales worth $118K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DERM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.